Current status of clinically available bioresorbable scaffolds in percutaneous coronary interventions

Drug-eluting stents (DES) are widely used as first choice devices in percutaneous coronary interventions. However, certain concerns are associated with the use of DES, i.e. delayed arterial healing with a subsequent risk of neo-atherosclerosis, late stent thrombosis and hypersensitivity reactions to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neth Heart J
Main Authors: Felix, Cordula, Everaert, Bert, Diletti, Roberto, Van Mieghem, Nicolas, Daemen, Joost, Valgimigli, Marco, de Jaegere, Peter P., Zijlstra, Felix, Regar, Evelyn, Simsek, Cihan, Onuma, Yoshinobu, van Geuns, Robert-Jan M.
Formato: Artigo
Idioma:Inglês
Publicado em: Bohn Stafleu van Loghum 2015
Assuntos:
Review Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4352158/
https://ncbi.nlm.nih.gov/pubmed/25626697
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12471-015-0652-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados